Eli Lilly set to acquire Centessa Pharma in $6.3B deal
Source: Reuters
Eli Lilly announced Tuesday that it will acquire Centessa Pharmaceuticals in a deal valued at approximately $6.3 billion, News.Az reports, citing Reuters.
The acquisition aims to strengthen Eli Lilly’s portfolio and advance treatments for sleep-wake disorders.
By Nijat Babayev
Similar news
